{"id":"https://openalex.org/W4200575428","doi":"https://doi.org/10.1192/bja.2021.65","title":"Treatment-resistant depression: therapeutic options when first-line treatments fail","display_name":"Treatment-resistant depression: therapeutic options when first-line treatments fail","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-20","ids":{"openalex":"https://openalex.org/W4200575428","doi":"https://doi.org/10.1192/bja.2021.65"},"language":"en","primary_location":{"id":"doi:10.1192/bja.2021.65","doi":"https://doi.org/10.1192/bja.2021.65","is_oa":false,"landing_page_url":"https://doi.org/10.1192/bja.2021.65","pdf_url":null,"source":{"id":"https://openalex.org/S2764648900","display_name":"BJPsych Advances","issn_l":"2056-4678","issn":["2056-4678","2056-4686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJPsych Advances","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200575428"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048513337","display_name":"Chloe Wigg","orcid":"https://orcid.org/0000-0003-2800-1235","observed_orcids":["https://orcid.org/0000-0003-2800-1235"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Chloe Wigg","raw_affiliation_strings":["A research assistant in the Psychopharmacology and Emotion Research Laboratory of the Department of Psychiatry, University of Oxford, and holds an MRes in Cognitive Neuroscience from the Institute of Cognitive Neuroscience, University College London, UK. She works on studies exploring emotional cognition and the effects of pharmacological interventions on healthy individuals and people with major depressive disorder. Her ultimate interest is the understanding of the pathophysiological mechanisms associated with depression and anxiety, their clinical application and potential for treatment development (both pharmacological and psychological"],"raw_orcid":"https://orcid.org/0000-0003-2800-1235","affiliations":[{"raw_affiliation_string":"A research assistant in the Psychopharmacology and Emotion Research Laboratory of the Department of Psychiatry, University of Oxford, and holds an MRes in Cognitive Neuroscience from the Institute of Cognitive Neuroscience, University College London, UK. She works on studies exploring emotional cognition and the effects of pharmacological interventions on healthy individuals and people with major depressive disorder. Her ultimate interest is the understanding of the pathophysiological mechanisms associated with depression and anxiety, their clinical application and potential for treatment development (both pharmacological and psychological","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052704510","display_name":"Sara Costi","orcid":"https://orcid.org/0000-0002-7937-8596","observed_orcids":["https://orcid.org/0000-0002-7937-8596"]},"institutions":[{"id":"https://openalex.org/I2802171185","display_name":"Oxford Health NHS Foundation Trust","ror":"https://ror.org/04c8bjx39","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802171185"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Sara Costi","raw_affiliation_strings":["A research-trained psychiatrist and currently a Wellcome Trust Doctoral Training Fellow in the Psychopharmacology and Emotion Research Laboratory of the Department of Psychiatry, University of Oxford, and an Honorary Clinical Fellow with Oxford Health NHS Foundation Trust, UK. She is also a clinical instructor in the Depression and Anxiety Center for Discovery and Treatment, within the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai, New York, USA. Her works focus on the study of biological and experimental therapeutic approaches aiming at elucidating the fundamental mechanisms underlying stress-related disorders in humans, including major depressive disorder, post-traumatic stress disorder and anxiety disorders"],"raw_orcid":"https://orcid.org/0000-0002-7937-8596","affiliations":[{"raw_affiliation_string":"A research-trained psychiatrist and currently a Wellcome Trust Doctoral Training Fellow in the Psychopharmacology and Emotion Research Laboratory of the Department of Psychiatry, University of Oxford, and an Honorary Clinical Fellow with Oxford Health NHS Foundation Trust, UK. She is also a clinical instructor in the Depression and Anxiety Center for Discovery and Treatment, within the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai, New York, USA. Her works focus on the study of biological and experimental therapeutic approaches aiming at elucidating the fundamental mechanisms underlying stress-related disorders in humans, including major depressive disorder, post-traumatic stress disorder and anxiety disorders","institution_ids":["https://openalex.org/I2802171185","https://openalex.org/I40120149","https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5048513337"],"corresponding_institution_ids":["https://openalex.org/I40120149","https://openalex.org/I45129253"],"apc_list":{"value":2190,"currency":"USD","value_usd":2190},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"1","first_page":"4","last_page":"8"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":1.0},{"id":"https://openalex.org/keywords/antidepressant-augmentation","display_name":"antidepressant augmentation","score":0.9399999976158142},{"id":"https://openalex.org/keywords/antidepressant-switching","display_name":"antidepressant switching","score":0.9120000004768372},{"id":"https://openalex.org/keywords/mianserin","display_name":"mianserin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8889999985694885},{"id":"https://openalex.org/keywords/antidepressant-non-response","display_name":"antidepressant non-response","score":0.6620000004768372},{"id":"https://openalex.org/keywords/long-term-effects","display_name":"long-term effects","score":0.46700000762939453}],"concepts":[{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6798107028007507},{"id":"https://openalex.org/C2780831388","wikidata":"https://www.wikidata.org/wiki/Q416701","display_name":"Mianserin","level":4,"score":0.642584502696991},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6352604627609253},{"id":"https://openalex.org/C2777146004","wikidata":"https://www.wikidata.org/wiki/Q14949826","display_name":"CLARITY","level":2,"score":0.6274198889732361},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5966020822525024},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5139815211296082},{"id":"https://openalex.org/C3019858935","wikidata":"https://www.wikidata.org/wiki/Q4340209","display_name":"Depressive symptoms","level":3,"score":0.48109763860702515},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4711930751800537},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4543364644050598},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.35560375452041626},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.1457776129245758},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.05786171555519104},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1192/bja.2021.65","doi":"https://doi.org/10.1192/bja.2021.65","is_oa":false,"landing_page_url":"https://doi.org/10.1192/bja.2021.65","pdf_url":null,"source":{"id":"https://openalex.org/S2764648900","display_name":"BJPsych Advances","issn_l":"2056-4678","issn":["2056-4678","2056-4686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJPsych Advances","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W149937157","https://openalex.org/W1472599296","https://openalex.org/W1916823056","https://openalex.org/W1940295429","https://openalex.org/W2099328792","https://openalex.org/W2149402043","https://openalex.org/W2201143031","https://openalex.org/W2293194104","https://openalex.org/W2341353168","https://openalex.org/W2405804353","https://openalex.org/W2579967741","https://openalex.org/W2906992465","https://openalex.org/W2948548704","https://openalex.org/W2981767691","https://openalex.org/W2999837842"],"related_works":["https://openalex.org/W2231645441","https://openalex.org/W2129388599","https://openalex.org/W7161631622","https://openalex.org/W4211214087","https://openalex.org/W2196041519","https://openalex.org/W2210972651","https://openalex.org/W2123484239","https://openalex.org/W4408542501","https://openalex.org/W1969922688","https://openalex.org/W2069840329"],"abstract_inverted_index":{"SUMMARY":[0],"The":[1],"Cochrane":[2],"review":[3,57],"by":[4,101],"Davies":[5],"et":[6],"al":[7],"aimed":[8],"to":[9,41,79,85,91],"address":[10],"the":[11,16,26,63,76,92,107,114,118],"lack":[12,122],"of":[13,20,29,46,95,123],"clarity":[14],"on":[15,110],"risks":[17],"and":[18,22,58,97,113],"benefits":[19],"switching":[21],"augmentation":[23],"strategies":[24],"in":[25,32,117],"pharmacological":[27],"treatment":[28,48],"treatment-resistant":[30],"depression":[31],"adults":[33],"who":[34],"did":[35],"not":[36],"respond":[37],"(or":[38],"partially":[39],"responded)":[40],"at":[42,49],"least":[43],"4":[44],"weeks":[45],"antidepressant":[47,65],"a":[50,121],"recommended":[51],"dose.":[52],"This":[53],"commentary":[54],"assesses":[55],"their":[56,59],"conclusion":[60],"that":[61],"augmenting":[62],"current":[64],"with":[66,69,88],"mianserin":[67],"or":[68,104],"an":[70],"antipsychotic":[71],"improves":[72],"depressive":[73],"symptoms":[74],"over":[75],"short-term":[77],"(8":[78],"12":[80],"weeks).":[81],"Their":[82],"results":[83],"need":[84],"be":[86],"treated":[87],"caution":[89],"owing":[90],"small":[93],"body":[94],"evidence":[96,109],"individual":[98],"comparisons":[99],"supported":[100],"one,":[102],"two":[103],"three":[105],"studies,":[106],"limited":[108],"long-term":[111],"effects":[112],"significant":[115],"gaps":[116],"literature":[119],"(e.g.":[120],"studies":[124],"assessing":[125],"dose":[126],"increases).":[127]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200575428","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2021-12-31T00:00:00"}
